Stephanie Ruez

6PUBLICATIONS
6CO-AUTHORS
Natural products and bioactive compoundsPredictive and prognostic markersLiquid biopsiesCarbon capture engineering (excl. sequestration)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 04, 2026
Challenging the specificity of chlorzoxazone and 4-nitrophenol as marker substrates for CYP2E1 activity in Supersomes™.

|May 20, 2026
Differential induction of hepatic CYP enzymes by tobacco products and e-cigarettes: recommendation to rethink smoking status in clinical pharmacology.

|Feb 16, 2026
Extending a liver-based model to lung and intestine: a comparative study of CYP1A1 and CYP1A2 induction by cigarette smoke in human in vitro models.

Ann-Kathrin Lenich, Wataru Kishimoto, Hiroshi Nakase

|Nov 30, 2025
Insights from a novel in vitro cigarette smoke induction model: comparison of 24 primary human hepatocyte donors of diverse demographics and multiple sources.

Ann-Kathrin Lenich, Stephanie Ruez

|Jul 20, 2025
Evaluating CYP enzyme induction by cigarette smoking: a new in vitro approach using primary human hepatocytes.

Ann-Kathrin Lenich, Stephanie Ruez

|May 07, 2024
Lack of CYP3A4 protein induction despite mRNA induction in primary hepatocytes exposed to rifabutin as a possible explanation for its low interaction risk in vivo.

Julie Nilles, Dirk Theile, Johanna Weiss

Pageof 1

Frequent Collaborators

5 joint publications

Ann-Kathrin Lenich

1 joint publications

Wataru Kishimoto

1 joint publications

Hiroshi Nakase

1 joint publications

Hiroyuki Mizuguchi